Discover how Ergomed transforms challenges into achievements in oncology trials.
Our latest case study highlights a Phase II Study in Gynecologic Oncology, focusing on recurrent, platinum-sensitive cancers such as high-grade epithelial ovarian, primary peritoneal, and fallopian tube cancers. With stringent eligibility requirements and tight timelines, this trial faced significant hurdles in patient enrollment and country-specific approval delays.
See how Ergomed’s Study Physician Service (SPS) fostered strong site relationships, strategic support, and tailored inclusion plans, accelerating patient enrollment and surpassing trial targets. Download the full case study to learn how Ergomed empowers oncology research success.
